Department of Health and Human Services January 27, 2016 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2016-01671
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Notice of Interest Rate on Overdue Debts
Document Number: 2016-01649
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services, Office of the Secretary
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Public Health Service Guideline on Infectious Disease Issues in Xenotransplantation
Document Number: 2016-01638
Type: Notice
Date: 2016-01-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Public Notification of Emerging Postmarket Medical Device Signals ('Emerging Signals'); Draft Guidance for Industry and Food and Drug Administration Staff; Extension of Comment Period
Document Number: 2016-01610
Type: Notice
Date: 2016-01-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is extending the comment period for the draft guidance for Industry and Food and Drug Administration Staff entitled ``Public Notification of Emerging Postmarket Medical Device Signals ('Emerging Signals').'' A notice of the availability of the draft guidance and our request for comments appeared in the Federal Register of December 31, 2015. We initially established February 29, 2016, as the deadline for the submission of requested comments that can help improve the Agency's policy for notifying the public about medical device ``emerging signals.'' The Agency is taking this action due to the unanticipated high-level of interest from external stakeholders and the medical device community and will allow interested persons additional time to submit comments.
HHS-Operated Risk Adjustment Methodology Meeting; March 31, 2016
Document Number: 2016-01584
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services
This notice announces the rescheduling of the March 25, 2016 meeting on the HHS-operated risk adjustment program, which is open to the public. The purpose of this stakeholder meeting is to solicit feedback on the HHS-operated risk adjustment methodology and to discuss potential improvements to the HHS risk adjustment methodology for the 2018 benefit year and beyond. This meeting, the ``HHS-operated Risk Adjustment Methodology Conference,'' will allow issuers, States, and other interested parties to discuss the contents of a White Paper to be published in advance of this meeting. This meeting will also provide an opportunity for participants to ask clarifying questions. The comments and information HHS obtains through this meeting may be used in future policy making for the HHS risk adjustment program.
National Human Genome Research Institute; Notice of Closed Meeting
Document Number: 2016-01528
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Nursing Research Notice of Closed Meetings
Document Number: 2016-01527
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 2016-01526
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services, National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Document Number: 2016-01525
Type: Notice
Date: 2016-01-27
Agency: Department of Health and Human Services, National Institutes of Health